COMMUNIQUÉS West-GlobeNewswire

Sharps Compliance Adds Sharon R. Gabrielson, Chair of Mayo Clinic’s Global Business Solutions, to Board of Directors
26/02/2019
HOUSTON, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national provider of comprehensive waste management solutions including medical, [...]
SELLAS Life Sciences Announces Review of Strategic Alternatives
26/02/2019
Phase 1/2 basket trial of lead clinical candidate, galinpepimut-S (GPS), plus Keytruda ® (pembrolizumab) ongoing; Phase 3 registrational study for GPS monotherapy in acute myeloid leukemia (AML) planned Discussions on [...]
SpineX Names Scientific Advisory Board to Guide Development of Non-Invasive Medical Devices for Neuromodulation of the Spine
26/02/2019
LOS ANGELES, Feb. 26, 2019 (GLOBE NEWSWIRE) -- SpineX, a developer of non-invasive medical devices to address a broad range of medical conditions through the neuromodulation of the spinal cord to restore function lost [...]
Catalyst Pharmaceuticals Announces Publication of Phase 3 Clinical Trial Data for Firdapse® for the Treatment of Lambert-Eaton Myasthenic Syndrome
26/02/2019
CORAL GABLES, Fla., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
Blessing Health System expands Allscripts partnership with clinical and financial solutions
26/02/2019
Health system extends and further expands portfolio to provide integrated platform that includes clinical and financial solutions for both acute and ambulatory settings CHICAGO, Feb. 26, 2019 (GLOBE NEWSWIRE) -- [...]
Protech Home Medical Releases Q1 2019 Results; Posts Revenue Growth of 17% and Adjusted EBITDA Growth of 186% Year Over Year
26/02/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Protech Home [...]
Immutep to Present at Upcoming Industry Conferences
26/02/2019
SYDNEY, Australia, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (Immutep or the Company), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]
BioCorRx Partners with IRISYS for Manufacturing of BICX102 Naltrexone Implant for Treatment of Opioid Use Disorder
26/02/2019
ANAHEIM, CA, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (“Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, announced today [...]
IRIDEX to Report Fourth Quarter and 2018 Financial Results on March 5, 2019
26/02/2019
MOUNTAIN VIEW, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the fourth quarter and full year 2018 after the close of trading [...]
Reminder: Investor Conference Call Today, February 26, 2019; Management to Provide Update on Initiatives & Strategic Plans, Call-in Details
26/02/2019
MIRAMAR, FL, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation ( www.generex.com ) (OTCQB: GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced the following access [...]
MannKind Corporation Fourth Quarter and Year-End 2018 Earnings Call
26/02/2019
Conference Call to Begin Today at 9:00 AM ET 4Q 2018 Total Revenues were $16.0 million; 254% growth vs. 4Q 2017 4Q 2018 Afrezza Net Revenue was $5.7 million; 28% growth vs. 4Q 2017 on a GAAP basis and 86% when adjusted [...]
VBL Presents New Data on the Potential of its Novel VB-600 Platform for Nonalcoholic Steatohepatitis (NASH) and Rheumatoid Arthritis (RA)
26/02/2019
TEL AVIV, Israel, Feb. 26, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), (the “Company”) today announced new data implicating the potential of its VB-600 platform of antibodies targeting MOSPD2 (motile [...]
Avalon GloboCare Announces Filing of Provisional Patent Applications for AVA-101, a Novel Transposon-Based, Multi-Targeted CAR-T Therapy
26/02/2019
AVA-101 designed to enhance efficacy and overcome safety challenges of current CAR-T immune-oncology therapeutics AVA-101 represents a first-in-class transposon-based Chimeric Antigen Receptor (CAR) system targeting [...]
OPKO Health to Announce Fourth Quarter 2018 Financial Results on February 27, 2019
26/02/2019
MIAMI, Feb. 26, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to announce its operating and financial results for the three and twelve months ended December 31, 2018 as well as provide guidance on [...]
Centura Health Joins Innovative Movement for One-Stick Hospitalization
26/02/2019
Partners with Fast Company’s Most Innovative Company recipient, Velano Vascular, to deliver PIVO to inpatients in Colorado and Kansas ENGLEWOOD, Colo., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Centura Health, the region’s [...]
Philips introduces IntelliSpace Portal 11 at ECR 2019 to support diagnostic confidence
26/02/2019
February 26, 2019 Latest release of Philips advanced visualization platform continues to build on innovations in intelligent clinical applications, hospital network connectivity, and patient data security Amsterdam, the [...]
Dermira to Present New Analyses of the Glycopyrronium Tosylate Clinical Program at the 77th American Academy of Dermatology Annual Meeting
26/02/2019
MENLO PARK, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
CareDx to Participate in the Cowen and Company 39th Annual Health Care Conference
26/02/2019
BRISBANE, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
Inhibikase Therapeutics Files Two Investigational New Drug Applications for IkT-148009, a Disease-Modifying Therapy for Parkinson’s Disease
26/02/2019
ATLANTA and BOSTON, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc., a pharmaceutical company developing protein kinase inhibitors for treatment of neurological infections and neurodegenerative diseases [...]

Pages